Panagora Asset Management Inc Arcturus Therapeutics Holdings Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$25.79 - $42.11 $411,376 - $671,696	-15,951 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$38.75 - $86.92 $361,188 - $810,181	9,321 Added 140.59%	15,951 $659,000
Q4 2020 Feb 10, 2021	SELL	$34.61 - $123.66 $217,835 - $778,316	-6,294 Reduced 48.7%	6,630 $288,000
Q3 2020 Nov 13, 2020	SELL	$37.49 - $63.19 $300,782 - $506,973	-8,023 Reduced 38.3%	12,924 $554,000
Q2 2020 Aug 12, 2020	BUY	$12.66 - $58.27 $257,225 - $1.18 Million	20,318 Added 3230.21%	20,947 $979,000
Q3 2019 Nov 12, 2019	BUY	$8.8 - $14.5 $5,535 - $9,120	629 New	629 $6,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.